These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31418136)

  • 1. CRISPR editing-mediated antiviral immunity: a versatile source of resistance to combat plant virus infections.
    Ji X; Wang D; Gao C
    Sci China Life Sci; 2019 Sep; 62(9):1246-1249. PubMed ID: 31418136
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of CRISPR/Cas9 system in breeding of new antiviral plant germplasm.
    Zhang DW; Zhang CF; Dong F; Huang YL; Zhang Y; Zhou H
    Yi Chuan; 2016 Sep; 38(9):811-20. PubMed ID: 27644742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR technology to combat plant RNA viruses: A theoretical model for Potato virus Y (PVY) resistance.
    Hameed A; Shan-E-Ali Zaidi S; Sattar MN; Iqbal Z; Tahir MN
    Microb Pathog; 2019 Aug; 133():103551. PubMed ID: 31125685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Plant ssDNA Viruses with Engineered Miniature CRISPR-Cas14a.
    Khan MZ; Haider S; Mansoor S; Amin I
    Trends Biotechnol; 2019 Aug; 37(8):800-804. PubMed ID: 31023561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geneticists enlist engineered virus and CRISPR to battle citrus disease.
    Ledford H
    Nature; 2017 May; 545(7654):277-278. PubMed ID: 28516945
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential for gene editing in antiviral resistance.
    Pyott DE; Fei Y; Molnar A
    Curr Opin Virol; 2020 Jun; 42():47-52. PubMed ID: 32512313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editing plants for virus resistance using CRISPR-Cas.
    Green JC; Hu JS
    Acta Virol; 2017; 61(2):138-142. PubMed ID: 28523919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Molecular Immunity Against Plant Viruses.
    Zaidi SS; Tashkandi M; Mahfouz MM
    Prog Mol Biol Transl Sci; 2017; 149():167-186. PubMed ID: 28712496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Virus-Mediated Genome Editing in Plants Using the CRISPR/Cas9 System.
    Ali Z; Abul-faraj A; Li L; Ghosh N; Piatek M; Mahjoub A; Aouida M; Piatek A; Baltes NJ; Voytas DF; Dinesh-Kumar S; Mahfouz MM
    Mol Plant; 2015 Aug; 8(8):1288-91. PubMed ID: 25749112
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections.
    Wahid B; Usman S; Ali A; Saleem K; Rafique S; Naz Z; Ahsan Ashfaq H; Idrees M
    Viral Immunol; 2017 Oct; 30(8):552-559. PubMed ID: 28825529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge.
    Lee C
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas13a: Prospects for Plant Virus Resistance.
    Khan MZ; Amin I; Hameed A; Mansoor S
    Trends Biotechnol; 2018 Dec; 36(12):1207-1210. PubMed ID: 29903474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing the efficiency of CRISPR/Cas9-based gene editing by suppressing RNAi in plants.
    Wang X; Lu J; Lao K; Wang S; Mo X; Xu X; Chen X; Mo B
    Sci China Life Sci; 2019 Jul; 62(7):982-984. PubMed ID: 30863962
    [No Abstract]   [Full Text] [Related]  

  • 16. CRISPR/CAS9-Mediated Antiviral Activity: A Tool to Combat Viral Infection.
    Ashfaq UA; Khalid H
    Crit Rev Eukaryot Gene Expr; 2020; 30(1):45-56. PubMed ID: 32421984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity and evolution of class 2 CRISPR-Cas systems.
    Shmakov S; Smargon A; Scott D; Cox D; Pyzocha N; Yan W; Abudayyeh OO; Gootenberg JS; Makarova KS; Wolf YI; Severinov K; Zhang F; Koonin EV
    Nat Rev Microbiol; 2017 Mar; 15(3):169-182. PubMed ID: 28111461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial genome editing using the CRISPR/Cas12a system].
    Castagné P; Guingand A; Moderc A; Monard S
    Med Sci (Paris); 2018 May; 34(5):399-400. PubMed ID: 29900839
    [No Abstract]   [Full Text] [Related]  

  • 19. [The CRISPR/Cas system: a genome editing tool to develop animal models of viral infections].
    Castino G; Guillemet M; Joly A; Vignon A
    Med Sci (Paris); 2018 May; 34(5):403-405. PubMed ID: 29900841
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequence-specific nucleases as tools for enhancing disease resistance in crops.
    Nekrasov V
    Transgenic Res; 2019 Aug; 28(Suppl 2):75-80. PubMed ID: 31321687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.